The pooled results showed that compared to AGVI alone, the combination of AGVI with anti-VEGF drugs effectively reduces the probability of postoperative hyphema [RR = 0.24, 95% CI (0.15, 0.39), p < 0.001]. This evidence concerns the gene VEGFA and Hyphema.